Gabriel Plotkin Cooper Companies, Inc. Transaction History

Melvin Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$294.25 - $341.49 $29.4 Million - $34.1 Million	-100,000 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$279.29 - $336.89 $48.9 Million - $59 Million	-175,000 Reduced 63.64%	100,000 $33.7 Million
Q1 2019 May 15, 2019	BUY	$246.18 - $297.25 $6.15 Million - $7.43 Million	25,000 Added 10.0%	275,000 $81.4 Million
Q4 2018 Feb 14, 2019	BUY	$232.7 - $281.66 $58.2 Million - $70.4 Million	250,000 New	250,000 $63.6 Million

1.59M

Ticker COO
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 49,346,000
Market Cap $4.92B
Description
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...

Get notified when there are updates to the investment portfolio of Melvin Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Melvin Capital Management LP and Gabriel Plotkin with notifications on news.